ANASTROL
País: Israel
Idioma: anglès
Font: Ministry of Health
Alguns documents d’aquest producte actualment no estan disponibles, podeu enviar una sol·licitud al nostre servei d’atenció al client i us ho notificarem tan bon punt puguem obtenir-los.
Enviar sol.licitud.
Enviar sol.licitud.
ingredients actius:
ANASTROZOLE 1 MG
Disponible des:
PERRIGO ISRAEL AGENCIES LTD
Codi ATC:
L02BG03
formulario farmacéutico:
FILM COATED TABLETS
Vía de administración:
PER OS
Fabricat per:
HAUPT PHARMA MUNSTER GmbH, GERMANY
Grupo terapéutico:
ANASTROZOLE
indicaciones terapéuticas:
Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
Data d'autorització:
2011-04-01
